Category Archives: Parkinson’s Treatment

COVID-19 has prompted clinicians to change how they deliver care and to reallocate resources toward the most urgent needs on a global scale.1 Patients with diseases ranging from Parkinson disease to chronic pain have been forced to wait for extended periods of time for necessary interventions and treatments. Consequently, many have experienced higher levels of pain, depression, and an overall lower quality of life.2 Compounding this issue is the fact that patients with neurologic conditions, including movement disorders, and those with chronic conditions seem to be at higher risk for COVID-193 but may be reluctant to seek medical intervention in the midst of the pandemic.4 This reluctance has allowed certain chronic conditions to progress to urgent health issues.4 But it is not all bad news. The challenges COVID-19 presents are driving the adoption of digital and telehealth platforms around the world, particularly for patients with chronic conditions. Continue reading →

Disposables Geographic Segmentation The report offers an exhaustive assessment of different region-wise and country-wise Parkinsons Disease Treatment markets such as the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. North America, Europe, Asia-Pacific, Latin America, The Middle East and Africa What are the main takeaways from this report Continue reading →

This year, investigators throughout the globe shared their work with MRI, highlighting not only the additional ways the modality can be used, but also spotlighting its ability to outperform other scanning methods. A variety of developments demonstrated the wider role that MRI can play with cancer imaging, neurological disease detection, and even COVID-19 Continue reading →

Dozens of experiments are going on at any given time aboard the International Space Station. Research conducted in 2020 is advancing our understanding in areas of study from Parkinsons disease to combustion. Space station research results published this year came from experiments performed and data collected during the past 20 years of continuous human habitation aboard the orbiting laboratory Continue reading →

MOST of us can find some joy in the Christmas and New Year period even this year but just imagine what it would be like if you couldn't, or, indeed, if you took no pleasure in anything most people enjoy, from eating a lovely meal to going for a walk. This is how some people feel every day, owing to a condition called anhedonia. It is likely to get worse over the holidays too, according to Carmine Pariante, a professor of biological psychiatry at King's College London "because there is an expectation at this time of year that everybody must be happy". Continue reading →

Despite the coronavirus pandemic, there was plenty of good news in 2020 like a nurse capturing graduation photos of a child she helped care for in hospice. WASHINGTON In the past year, there has been a lot of focus on the global pandemic, national politics, social justice, unrest and a lot of gloom and doom. Despite all of that, there are always things worth celebrating, big and small. Continue reading →

MINNEAPOLIS, Dec. 30, 2020 /PRNewswire/ --Women who develop high blood pressure during pregnancy may be more likely to have lower scores on tests of memory and thinking skills 15 years later than women who did not develop high blood pressure during pregnancy, according to a new study published in the December 30,2020, online issue of Neurology, the medical journal of the American Academy of Neurology Continue reading →

Parkinsons Disease Treatment Market Report Coverage: Key Growth Factors & Challenges, Segmentation & Regional Outlook, Top Industry Trends & Opportunities, Competition Analysis, COVID-19 Impact Analysis & Projected Recovery, and Market Sizing & Forecast. A recent market research report added to repository of Credible Markets is an in-depth analysis of Global Parkinsons Disease Treatment Market. On the basis of historic growth analysis and current scenario of Parkinsons Disease Treatment market place, the report intends to offer actionable insights on global market growth projections Continue reading →

DUBLIN--(BUSINESS WIRE)--The "Parkinson's - Disease Insights and Market Forecasts to 2026" report has been added to ResearchAndMarkets.com's offering. "Parkinson's: Disease Insights and Market Forecasts to 2026" report delivers an in-depth understanding of the disease, historical & forecasted epidemiology of Parkinson's disease in the US, EU5 (Germany, France, Italy, Spain, UK), and Japan and the historical & forecasted market size, for Parkinson's , drug wise in $ sales and patient numbers at global level and in the US, EU5 (Germany, France, Italy, Spain, UK), Australia and Canada till 2026. Epidemiology Forecasts to 2026: This section of the report provides the overview of Parkinson's diagnosed prevalent and treated patients in the US, EU5 and Japan market year wise starting from 2018 till 2026 Continue reading →

December 10, 2020 07:00 ET | Source: Newscope Capital Corporation TORONTO, Dec. 10, 2020 (GLOBE NEWSWIRE) -- PharmaTher Inc., (PharmaTher or the Company), a wholly-owned subsidiary of Newscope Capital Corporation (CSE: PHRM) (OTC Pink: PHRRF) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that it has been granted a Pre-Investigational New Drug (PIND) meeting with the U.S. Food and Drug Administration (FDA) for the clinical development of ketamine in Parkinsons disease and its proposed Phase 2 clinical study for ketamine in the treatment of levodopa-induced dyskinesia associated with Parkinsons disease (LID-PD) Continue reading →